Time for action against antimicrobial resistance
Interviewee/Contributor
Lars Rebien Sørensen
Organisation
Novo Nordisk Foundation
Research Directory
Why we all go to JP Morgan year after year
Interviewee/ContributorEdwin MosesOrganisationAchilles Therapeutics LtdDiscovery suggests new approach to liver disease
Interviewee/ContributorPeter CharlishOrganisationMedNousNew treatments for macular degeneration
Interviewee/ContributorPeter CharlishOrganisationMedNousThe US continues to lead in oncology approvals
Interviewee/ContributorBruno PagliaraOrganisationMedNousTruffle Capital launches new technology funds
Interviewee/ContributorPhilippe PoulettyOrganisationTruffle CapitalWelcome to the Euro-Nasdaq waltz
Interviewee/ContributorWilliam EllingtonOrganisationMedNousThe role of relapse vaccines in fighting cancer
Interviewee/ContributorErik MantingOrganisationDCPrime BVRNA epigenetics is coming of age
Interviewee/ContributorOliver RauschOrganisationStorm Therapeutics LtdIon channel drug discovery and modern medicine
Interviewee/ContributorMarc RogersOrganisationMetrion Biosciences Ltd